INC Research Holdings, Inc. (NASDAQ:INCR) – Research analysts at KeyCorp decreased their Q4 2017 earnings estimates for INC Research Holdings in a research note issued on Monday. KeyCorp analyst D. Hooker now forecasts that the company will earn $0.65 per share for the quarter, down from their previous forecast of $0.66. KeyCorp currently has a “Overweight” rating and a $68.00 target price on the stock.

Other research analysts have also issued reports about the stock. TheStreet upgraded shares of INC Research Holdings from a “c” rating to a “b-” rating in a research report on Monday, April 17th. Jefferies Group LLC restated a “buy” rating and set a $51.00 target price on shares of INC Research Holdings in a research report on Friday, April 21st. Goldman Sachs Group, Inc. (The) lowered shares of INC Research Holdings from a “conviction-buy” rating to a “buy” rating and set a $51.00 target price on the stock. in a research report on Wednesday, March 1st. SunTrust Banks, Inc. upgraded shares of INC Research Holdings from a “hold” rating to a “buy” rating and upped their target price for the stock from $48.00 to $67.00 in a research report on Wednesday, May 31st. Finally, Zacks Investment Research lowered shares of INC Research Holdings from a “buy” rating to a “hold” rating in a research report on Tuesday, March 7th. One investment analyst has rated the stock with a sell rating, two have assigned a hold rating and seven have assigned a buy rating to the company’s stock. The company presently has an average rating of “Buy” and a consensus price target of $60.38.

Earnings History and Estimates for INC Research Holdings (NASDAQ:INCR)

TRADEMARK VIOLATION NOTICE: This article was originally reported by Financial Market News and is owned by of Financial Market News. If you are accessing this article on another website, it was illegally copied and republished in violation of U.S. and international copyright and trademark law. The original version of this article can be accessed at https://www.financial-market-news.com/2017/06/17/q4-2017-eps-estimates-for-inc-research-holdings-inc-incr-reduced-by-analyst.html.

Shares of INC Research Holdings (NASDAQ INCR) opened at 59.75 on Thursday. INC Research Holdings has a one year low of $36.70 and a one year high of $61.10. The firm has a 50-day moving average of $54.01 and a 200 day moving average of $50.24. The company has a market cap of $3.23 billion, a price-to-earnings ratio of 28.43 and a beta of 1.47.

INC Research Holdings (NASDAQ:INCR) last released its earnings results on Wednesday, May 10th. The company reported $0.60 EPS for the quarter, beating the Thomson Reuters’ consensus estimate of $0.55 by $0.05. The firm had revenue of $252.10 million during the quarter, compared to analysts’ expectations of $250.76 million. INC Research Holdings had a net margin of 7.37% and a return on equity of 43.17%. The business’s quarterly revenue was up 1.2% compared to the same quarter last year. During the same period in the prior year, the company earned $0.58 EPS.

Several hedge funds have recently added to or reduced their stakes in INCR. Fifth Third Bancorp raised its stake in INC Research Holdings by 5.4% in the first quarter. Fifth Third Bancorp now owns 2,904 shares of the company’s stock valued at $133,000 after buying an additional 149 shares in the last quarter. Argent Capital Management LLC raised its stake in INC Research Holdings by 2.3% in the first quarter. Argent Capital Management LLC now owns 7,695 shares of the company’s stock valued at $353,000 after buying an additional 170 shares in the last quarter. Teacher Retirement System of Texas raised its stake in INC Research Holdings by 4.0% in the first quarter. Teacher Retirement System of Texas now owns 4,426 shares of the company’s stock valued at $203,000 after buying an additional 170 shares in the last quarter. Massmutual Trust Co. FSB ADV raised its stake in INC Research Holdings by 4.5% in the first quarter. Massmutual Trust Co. FSB ADV now owns 4,629 shares of the company’s stock valued at $212,000 after buying an additional 200 shares in the last quarter. Finally, Usca Ria LLC raised its stake in INC Research Holdings by 4.9% in the first quarter. Usca Ria LLC now owns 9,075 shares of the company’s stock valued at $416,000 after buying an additional 425 shares in the last quarter. Institutional investors and hedge funds own 98.70% of the company’s stock.

In other news, CEO Alistair Macdonald sold 9,467 shares of the stock in a transaction that occurred on Monday, May 1st. The shares were sold at an average price of $45.00, for a total value of $426,015.00. Following the sale, the chief executive officer now directly owns 83,935 shares in the company, valued at $3,777,075. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, CAO Christopher L. Gaenzle sold 4,733 shares of the stock in a transaction that occurred on Monday, April 3rd. The shares were sold at an average price of $45.70, for a total transaction of $216,298.10. Following the completion of the sale, the chief accounting officer now owns 53,050 shares in the company, valued at $2,424,385. The disclosure for this sale can be found here. 0.24% of the stock is owned by corporate insiders.

INC Research Holdings Company Profile

INC Research Holdings, Inc is a global contract research organization (CRO). The Company focuses on Phase I to Phase IV clinical development services for the biopharmaceutical and medical device industries. The Company operates through two segments: Clinical Development Services and Phase I Services.

Receive News & Ratings for INC Research Holdings Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for INC Research Holdings Inc. and related companies with MarketBeat.com's FREE daily email newsletter.